How Patients Prevent and Recover Speedier from Covid-19 Using These Protocols

Dr. Manny Espinoza was a critically ill COVID-19 patient who was quickly deteriorating. His wife, also a physician, learned of the FLCCC’s MATH+ Hospital Treatment Protocol and acted quickly to have her husband flown to United Memorial Medical Center in Houston to give him access to the drug that would save his life.

The FLCCC Alliance – On a Mission to Save Thousands & Slow the Pandemic

Get The Fundamentals of The Preventative and Early Outpatient Front Line COVID-19 Critical Care Alliance Protocols

The FLCCC Alliance was organised in March, 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Their MATH+ Hospital Treatment Protocol – introduced in March, 2020, has saved tens of thousands of patients who were critically ill with COVID-19.

Academy Award winning actor Louis Gossett, Jr. tells his personal story of surviving COVID-19 after learning about a remarkably effective re-purposed medicine

Clinical Trials Evidence for Ivermectin in COVID-19

Summary of results reported in ivermectin Trials for Covid-19. 06/27/21.

Newspaper/Journal Reports and Articles


Ivermectin, an anti-parasitic medicine whose discovery won the Nobel Prize in 2015, has proven, highly potent, anti-viral and anti-inflammatory properties in laboratory studies. In the past 4 months, numerous, controlled clinical trials from multiple centers and countries worldwide are reporting consistent, large improvements in COVID-19 patient outcomes when treated with Ivermectin.


July 29, 2020 | UK The BBC reports on Dr. Varon as “The Covid Hunter of Houston” Dr Joseph Varon says he has adapted a treatment protocol that has given his Covid-19 patients a 95% chance of recovery.


May 20, 2021 | USA The Drug that Cracked Covid by Michael Capuzzo New York Times best-selling author Michael Capuzzo writes in Mountain Home the riveting, unbelievable story behind the story of why a family whose mother was dying of COVID, had to obtain a court-order to compel the hospital to give her a life-saving medicine. Capuzzo calls upon his journalist colleagues to “open their minds to legitimate, unreported doctors and therapies and write about all sides of the Ivermectin story, like journalists always have. It is a historic opportunity. For the first time in the long journey from Gutenberg to Google, journalists may be the ones to save the world.


August 5, 2020 | USA The Covid drug wars that pitted doctor vs. doctor
Dr. Pierre Kory (FLCCC) interviewed in a New York Times article on the fights over COVID-19 treatments between bedside physicians and hospital administrators demanding randomized controlled trials


Data which further illuminates the protective role of ivermectin against COVID-19 comes from a study of nursing home residents in France which reported that in a facility that suffered a scabies outbreak where all 69 residents and 52 staff were treated with ivermectin (Behera et al., 2020), they found that during the time period surrounding this event, 7/69 residents fell ill with COVID-19 (10.1%). In this group with an average age of 90 years, only one resident required oxygen support and no resident died. In a matched control group of residents from surrounding facilities, they found 22.6% of residents fell ill and 4.9% died.

Ivermectin Adoption Across The Globe

Source: Global ivermectin adoption for COVID-19 – (constantly updated)


Really Helpful


Thanks Peter!


This Could Save Lives


Great Work. Thanks!

Hey, I'm Peter Smanjak. I work in Health Risk and Regenerative Wellness.

Our work and passion is to research, consolidate and share alternative and functional medicine insights that bring about healing in the body, mind and soul.

These Insights Will Help You For -

Key Secrets to Reducing the Risk Of Covid-19

To better understand one’s risk to disease and now the Coronavirus-19, it is important to take a risk-based view . The risk-based view considers the following:


Secret One

Identify the risk to contracting the virus through the various mechanism or considering the state of the immune response.


Secret Two

Evaluate the various risks and determine possible consequences and impact of on oneself or family member or employee.


Secret Three

Implement the correct measures to minimise contracting the virus and or measures that are put inplace should one become infected with the virus.


Secret Four

Make sure a sufficient funding mechanism is in place to fund the preventative protocols and treatments should one end up in hospital.

Be Aware Of Your Health Risk Before Embarking Upon Any Protocol or Vaccine

Making an informed decision is vital as your life and that of family depends on it!

Peter Smanjak provides users with online access to learn about efforts to evaluate and recommend optimal treatments for various health conditions, diseases and in specific cases, COVID-19 based upon available research of experts in their field. The description of these approaches does not create a doctor/patient relationship with the user nor a consultation relationship with user’s physician. Peter Smanjak provides users online information and access via email or telephone, but nothing provided on our site creates a physician-patient relationship nor does it constitute a physician consultation. Information is not intended as a replacement for diagnosis or treatment by your doctor. Nothing on this Website provides medical advice or any form of diagnosis or treatment of any kind to web users. Medical decisions should be made by the patient’s physician who can consider a review of the materials and knowledge of the patient’s medical history and condition. All information provided by Peter Smanjak or in connection with the Website are offered to promote research and experience by trained healthcare and alternative healthcare professionals of possible treatments and for general informational purposes and are not medical advice to users.


The Ivermectin/Mask+ Protocol has been developed by experienced physicians treating hospitalised COVID-19 patents; at this time, it has not been adopted as a medical consensus. While clinical experience and research to-date is promising, these products have not been proven to be safe and effective by prospective, randomized double-blind, placebo-controlled studies acceptable to SA medical associations and regulatory bodies.

In relation to compounding the court order confirmed that medicines containing Ivermectin may be compounded and accessed in accordance with the provisions under the Medicines Act (section 14.4). Further, unregistered Ivermectin-containing finished pharmaceutical products for human use remain accessible only under the Programme through the authorised suppliers of such products. The Controlled Compassionate Use Programme remains firmly in place.

SAHPRA has not approved Ivermectin or the Mask+ protocol for COVID-19 and such use is considered “off-label.” Based on increasing evidence, the National Institutes of Health (NIH) recently upgraded its Ivermectin recommendation from “do not use” to “neither for nor against,” the same as for monoclonal antibodies and convalescent plasma. No treatment, however, including Ivermectin or the Mask+ Protocol, has been accepted by our public health system as proven to prevent, mitigate or treat COVID-19.

High Court Case Order